Role of Gunja beeja lepa in low back pain

Effectiveness of Gunja (Abrus precatorius Linn.) beeja lepa in the management of Gridhrasi (Sciatica)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020985

Enrollment

Registered

2019-08-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhere

Interventions

Intervention1: Gunja Beeja Lepa: Gunja Beeja Lepa will be given in Quantity sufficient dosage twice a day route of administration will be local application for 7 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as the case of Gridhrasi (Sciatica) with the presenting symptoms of either sex. 2. Patients in the age group 30 to 50 years of age. 3. Patients with straight-leg raising (SLR) test (0-60 Degree) positive.

Exclusion criteria

Exclusion criteria: 1. Patients with Sensitivity test positive. 2. Monoplegia, paraplegia, hip joint arthritis, T.B. of spine, severe accidental cases and other surgical emergencies if any history present. 3. Pregnant and lactating women. 4. Patients with skin diseases or lesions

Design outcomes

Primary

Measure	Time frame
Relief in painTimepoint: 3rd and 7th day	—

Secondary

Measure	Time frame
Improvement in Locomotor functionsTimepoint: 3rd and 7th day	—

Countries

India

Contacts

Public ContactDr Sonali Chalakh

Mahatma Gandhi Ayurved College Hospital and Research Centre

spchalakh@gmail.com9850366073

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026